Free Trial

Johnson & Johnson (JNJ) SEC Filings & 10K Form

$164.38
-0.61 (-0.37%)
(As of 09/6/2024 ET)

Recent Johnson & Johnson SEC Filings

DateFilerForm TypeView
09/03/2024
3:48 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
1:05 PM
Johnson & Johnson (Filer)
Form N-PX
Annual Report of Proxy Voting Record of Registered Management Investment Company  
08/26/2024
3:26 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
3:35 PM
Johnson & Johnson (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
07/30/2024
8:06 PM
Johnson & Johnson (Filed by)
Rallybio Corp (Subject)
Form SC 13G
07/25/2024
3:02 PM
Johnson & Johnson (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2024
7:14 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
4:48 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:18 PM
Johnson & Johnson (Filer)
Form 11-K/A
06/24/2024
3:43 PM
Johnson & Johnson (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/24/2024
3:42 PM
Johnson & Johnson (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/06/2024
4:07 PM
HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:07 PM
Johnson & Johnson (Issuer)
Woods Eugene A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:10 PM
Johnson & Johnson (Filer)
Form SD
Specialized Disclosure Report  
05/21/2024
9:43 AM
Johnson & Johnson (Filer)
Form CERT
05/20/2024
4:17 PM
Johnson & Johnson (Filed by)
Kenvue Inc. (Subject)
Form SC 13G/A
05/20/2024
3:34 PM
Johnson & Johnson (Filer)
Form 8-A12B
05/20/2024
8:31 AM
Johnson & Johnson (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
Form 25-NSE
05/17/2024
10:21 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
5:05 AM
Johnson & Johnson (Filer)
Form 424B5
05/13/2024
7:36 AM
Johnson & Johnson (Filer)
Form 424B5
05/10/2024
4:14 PM
Johnson & Johnson (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
05/01/2024
6:00 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
6:09 AM
Johnson & Johnson (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
4:05 PM
Doudna Jennifer A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:05 PM
Johnson & Johnson (Issuer)
Johnson Paula A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:05 PM
Johnson & Johnson (Issuer)
Joly Hubert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:06 PM
Johnson & Johnson (Issuer)
McClellan Mark B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:06 PM
Johnson & Johnson (Issuer)
WEINBERGER MARK A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:06 PM
Johnson & Johnson (Issuer)
MULCAHY ANNE M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:06 PM
Johnson & Johnson (Issuer)
Woods Eugene A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:06 PM
Adamczyk Darius (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:06 PM
Johnson & Johnson (Issuer)
West Nadja (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:06 PM
HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:06 PM
Beckerle Mary C (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
11:16 AM
Johnson & Johnson (Filer)
Form 8-K/A
04/16/2024
6:06 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
4:05 PM
Contineum Therapeutics, Inc. (Issuer)
Johnson & Johnson (Reporting)
Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/10/2024
4:12 PM
Contineum Therapeutics, Inc. (Subject)
Johnson & Johnson (Filed by)
Form SC 13G
04/05/2024
4:29 PM
Johnson & Johnson (Filed by)
Shockwave Medical, Inc. (Subject)
Form DFAN14A
03/27/2024
8:48 AM
Johnson & Johnson (Subject)
National Legal & Policy Center (Filed by)
Form PX14A6G
Biden's Successor: The Radical Threat to YOUR Savings! (Ad)

Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.

>> Get Your FREE Wealth Protection Guide <<
03/13/2024
3:28 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2024
3:36 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
6:42 AM
Johnson & Johnson (Filer)
Form ARS
03/13/2024
6:35 AM
Johnson & Johnson (Filer)
Form DEF 14A
03/13/2024
6:37 AM
Johnson & Johnson (Filer)
Form DEFA14A
03/13/2024
6:39 AM
Johnson & Johnson (Filer)
Form DEFA14A
03/06/2024
2:42 PM
CVRx, Inc. (Issuer)
Johnson & Johnson (Reporting)
Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:58 PM
Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:54 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:12 PM
Johnson & Johnson (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2024
4:23 PM
Ambrx Biopharma, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
02/15/2024
3:53 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Forminard Elizabeth (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Hait William (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Fasolo Peter (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Johnson & Johnson (Issuer)
Wengel Kathryn E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Johnson & Johnson (Issuer)
Swanson James D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Fasolo Peter (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Forminard Elizabeth (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Johnson & Johnson (Issuer)
Wolk Joseph J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Hait William (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Hait William (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Fasolo Peter (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Johnson & Johnson (Issuer)
Swanson James D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Forminard Elizabeth (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:25 PM
Johnson & Johnson (Issuer)
Wolk Joseph J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:25 PM
Johnson & Johnson (Issuer)
Wengel Kathryn E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:25 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:25 PM
Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
11:55 AM
Johnson & Johnson (Subject)
McEvoy Ashley (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2024
11:35 AM
Johnson & Johnson (Subject)
Taubert Jennifer L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/06/2024
3:24 PM
Johnson & Johnson (Subject)
McEvoy Ashley (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
4:07 PM
BiomX Inc. (Subject)
Johnson & Johnson (Filed by)
Form SC 13G/A
02/02/2024
3:52 PM
CVRx, Inc. (Subject)
Johnson & Johnson (Filed by)
Form SC 13G/A
02/02/2024
3:32 PM
Johnson & Johnson (Filed by)
Johnson & Johnson (Filed by)
Nanobiotix S.A. (Subject)
Form SC 13G/A
01/30/2024
11:46 AM
Johnson & Johnson (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/29/2024
3:50 PM
Ambrx Biopharma, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
01/24/2024
11:51 AM
Johnson & Johnson (Filed by)
Kenvue Inc. (Subject)
Form SC 13G
01/23/2024
6:45 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The solution to fast food’s wage hike crisis (Ad)

Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.

Learn more about this much-needed advancement and investment opportunity here.
01/09/2024
4:08 PM
Ambrx Biopharma, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
01/08/2024
4:22 PM
Ambrx Biopharma, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
01/08/2024
7:22 AM
Johnson & Johnson (Filer)
Form DEFA14A
12/08/2023
3:33 PM
Johnson & Johnson (Issuer)
Woods Eugene A. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/07/2023
4:17 PM
HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:42 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2023
6:52 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/30/2023
3:30 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2023
3:56 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:JNJ) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners